Podcasts about wcg

In this episode of WCG Talks Trials, Silvio Galea, chief data and analytics officer, and Bryan Wayne, vice president of imaging operations, both of WCG, explore the critical role of imaging in clinical trials. Together, they break down industry acronyms, unpack the process of independent image review, and discuss how WCG is contributing to the validation and implementation of AI-driven radiology solutions. Listen in as they share behind-the-scenes insights into core lab operations, the significance of sample size and study design, and how emerging technology is shaping the future of clinical research. Whether you are a clinical trial professional, healthcare innovator, or simply curious about the intersection of AI and research, this episode provides valuable perspectives on driving efficiency, accuracy, and better outcomes in clinical research imaging. For more information about WCG's imaging solutions, visit wcgclinical.com/imaging.  

From the mountains of Saudi Arabia to the ruins of Noah's Ark in Turkey, Joseph F. Dumond has spent over four decades uncovering prophetic patterns hidden in plain sight. His discoveries about the Jubilee cycles, the Red Heifer's coming sacrifice in 2026, and the shocking fulfillment of biblical prophecies in our headlines today… will shake you. Joseph F Dumond I was born in 1958 to an Anglican mother and a Catholic father. I was raised Catholic and married my high school sweetheart, Barbara, in 1978 after graduating in 1977 from Orangeville District Secondary School in Ontario, Canada.Barbara and I had our daughter in 1981, our son in 1982, and then later our third child—another son in 1990. We wanted to be good parents and began to attend the Catholic church weekly, but we learned very little about God at this time.In 1981, I first heard Herbert Armstrong teaching about the Sabbath on my car radio late one night on my way to work in Eastern Ontario. He was teaching about the ancestry of the French people, which I found very interesting as I worked on my family tree, but I was not able to write his contact information down while I drove.A few days later, I heard him again as I left from work and wrote in to request some material. That winter of 1981-82, I found myself studying the Bible unlike I had ever done in the past. I was desperately trying to prove wrong what he said about the Sabbath being Friday sunset to Saturday sunset. How could one billion Catholics be keeping the Sabbath on the wrong day?I worked seven days a week as a foreman, supervising natural gas pipeline workers. There was no way I could possibly take a day off to attend church on Saturday. But finally, after six months of solid day and night study, I could no longer discount just how clear Yehovah has always been on this matter and that we all should be keeping the Sabbath. I was forced to conclude the seventh day Saturday Sabbath had never changed, and that it was the Catholic Church that was to blame for changing the Saturday Sabbath to Sunday, so I began to attend the Worldwide Church of God (WCG) in April of 1982.About a month after my first visit, I learned about the Holy Days. Through those Holy Days—all of which are found in Leviticus 23—I was able to learn of Yehovah's divinely inspired plan for mankind and how it was all to come together. I attended the WCG from 1982-1994. Hebert Armstrong died in 1986 and the Church he left behind began to return to—and look more and more like—the Catholic Church. There were many splits during these years.I left the WCG after attending Sukkot in 1994. They were now serving communion which is what we did every Sunday in the Catholic faith. I began to study on my own from that week onward. Because my wife was not interested, I would leave the house each Saturday and drive to a deserted dead-end road and study there alone—and did so until 9/11 took place in 2001.The Sabbath after 9/11, I was attending the United Church of God (UCG) which was one of the many offshoots of the WCG. While there, I began to write just a few articles for the Good News Magazine and the monthly newspaper published by the UCG.In the winter of 2004-05, I heard about Michael Rood and Nehemia Gordon giving a teaching in Lansing, Michigan. I drove down and for the first time learned that God had a name, that the Hillel calendar I was currently following began in 358 C.E., and the original calendar used by Yehshua and the Apostles was the crescent moon to begin the month and the barley each spring to begin the year. Once again, I was being challenged in my beliefs. Once again, I began an intensive search to discover the truth.I was not sure which methodology was correct, so I decided to keep both and no one would know. The Holy Days would only be a couple days apart at the most. Then Nehemia announced the barley was Aviv and they would be keeping the Holy Days one month before those on the Hillel calendar. I decided to keep both calendars anyway, even though they would be 30 days apart. On Passover according to the barley, I discovered the proof scripture showing me absolutely which calendar was correct. It was when Yehshua said no man could know the day or the hour. Then on that same day through Qadesh La Yahweh Press, Yehovah showed me the Jubilee years, when they were, and how to prove them. They had written about 11 historical Sabbatical and Jubilee years.I was able to connect the curses of Leviticus 26 to these Jubilee cycles. I was then able to bridge the gap between the Old and New Testament chronologies because of the Jubilee cycles, one of which (the year they entered the Promised Land) I discovered when I did the Genesis chronology. This led me to know that the end of the 6th millennial day of mankind would be in 2044.This also led me to understand the prophecy of Daniel 9, which shows there are 70 Jubilee cycles from the Exodus—and it was not talking about Jesus. The middle of the 70th week, or 70th Jubilee cycle, was 2020. I began warning about 2020 starting in 2005. Then the COVID-19 pandemic impacted the entire world in 2020.In the WCG I had learned how the Holy Days of Leviticus 23 explained the plan of salvation, but it was not until I combined the Jubilee cycles with those Holy Days that it all came together.I had begun to talk to the brethren about all I was discovering and by August 2006 I was asked to leave the UCG. That same month I began our website, Sightedmoon.com. The internet was still new and growing fast. This is when we began to write a weekly newsletter and share all those things we were discovering about the Jubilee cycles and prophecy, which I had written up in short articles since Passover 2005.I never wanted to be someone who teaches religion. Never. But when I saw that no one else was speaking about the Sabbatical and Jubilee cycles and how they revealed end-time prophecy, I could no longer remain silent.In 2005, I took my first tour of Israel. In 2006, I mikveh'd (baptized) in the Gihon Spring and had hands laid on me. I have not been able to shut up since this time. Then in 2007, I went to Noah's Ark in eastern Turkey on the Iranian border to prove to myself if this was true and whether I could believe in the Bible. It was at this time that I also discovered I was in the Garden of Eden. After going to Israel and then Noah's Ark, I came away knowing the accuracy of the Bible. As of December 2024, I have been conducting my own tours of Israel, having now been there 25 times, as well as climbing Mount Sinai in Saudi Arabia in 2022 where I saw the Golden Calf Altar.I continued to explain my findings to people repeatedly through our website, or in various Bible study groups, but few understood. In 2008, a friend told me to publish my writings into a book so they all would be in one place.In 2009, I kept my first Sabbatical year and let our land rest, stocking up food the year before. I also published the Sabbatical and Jubilee Charts for the first time in 2009.Having never written a book before, I was able to publish my first book The Prophecies of Abraham in 2010. I was trying to explain everything I understood in one book. I felt the least qualified to teach or to write as my English communication skills were horrendous.I assumed everyone already knew all these things I was explaining and that I was just another person saying the same old things once again. To my amazement, they did not know these things, nor had they heard such teachings before. Those double checking what I was saying could not find fault.This book, along with the charts, compares various prophetic Jubilee cycles with our current 120th cycle. Luke speaks of the days of Noah and of Lot. This is only understood when you see each of their Jubilee cycles and compare it to our own. Then that scripture makes so much more sense. Then we discovered the seven years of plenty and the seven years of famine also confirmed what I was explaining.Many people could not understand how The Prophecies of Abraham demystified the Sabbatical and Jubilee years. To help them, in 2013, I then published Remembering the Sabbatical Year of 2016. I went into great detail and explained how to know when each and every Sabbatical and Jubilee year was. I walked the reader through each step in understanding how to figure this subject out, answering every question that has been raised about this subject.I was able to present all of this for the first time in 2013 at Sukkot in Fall Creek Falls State Park in Tennessee. I was able to record all of these teachings for the very first time on video. It was during this Sukkot that I was introduced to the Tombstones of Zoar for the very first time.But the brethren still had trouble understanding the 70 weeks of Daniel 9 in relation to the Jubilee cycles. These end-time prophecies needed yet another book to explain them in great detail. This led me to publish my 4th book in 2014, The 2300 Days of Hell. I originally wanted to call it the 70 Shabua of Daniel, but no one understood the title, so I changed it just before publishing. Once you see the charts for the Jubilee cycles, you can then see how they explain the meaning of the 70 Weeks of Daniel, which were sealed until the time of the end. That time is right now.The brethren can now see many things on the nightly news that this book explains: the deception of the Paris Accords or Climate Change, and the rise of military confrontations in the Middle East, EU, Iran and China. In 2014, there was a lot of hype about the Blood Moons. Our 5th book, The Blood Moons-The Elephant in the Room, is only available as an e-book through our website, Sightedmoon.com. It shows you how there were blood moons on each of the Jewish Holy Days in the spring and in the fall just before almost every major event in the Bible, all the way back to just before the death of Adam. It is a stunning book which can only be explained when you understand the Jubilee cycles.In 2019, I was convinced of the need to write our 6th book, It Was A Riddle Not A Command, because many people would write us and say that no man knows the day or the hour, and therefore you cannot know these end-time prophecies that you are teaching in your other books. It was always disappointing to see this response, as it showed they would not and could not learn any more than what they had already come to understand at their local church or assembly. They had stopped growing. They had never learned what that expression they so often used was actually telling them—the very day our Messiah was going to come back on.In order to prove to you what this Hebrew idiom actually does mean, we must look at a few other subjects, which will again deepen your understanding of the time when our Messiah was killed and of what is meant by Revelation 12. You will also learn that Yehshua always spoke in parables to purposely not reveal the information He was teaching about to the public. He wanted them to remain ignorant because they would not take the time to learn about Him in more detail.In the Parable of the Ten Virgins, I hope you will be just like the wise virgins who bought extra oil so that they had it when they needed it. The five foolish virgins had to go buy the oil because they did not have enough, but they were too late.I had stated publicly I would close our website if nothing happened in 2020 as we had been warning in our book The 2300 Days of Hell. COVID-19 did happen, and it proved our accuracy of the Jubilee cycles, but it even took us some time to realize just how huge COVID was and what that meant.My 7th book was published in 2021. The Mystery of the Jewish Rapture 2033 was addressing the rapture debate and showing from scriptures when it was to take place. In The Mystery of the Jewish Rapture 2033, we drill down on the Rapture itself and show you exactly where it is explained and the very day and year it is to take place on—exactly as your Bible shows you. Our book It Was A Riddle Not A Command also tells you the very day our Messiah is to come, so these last two books answer that burning desire most Christians have as to when these things are to take place. This answer is not possible to know though unless you understand the Sabbatical and Jubilee years.With the restrictions of COVID diminishing in 2022, and after having seen the Golden Calf Altar and Mount Sinai in Saudi Arabia, the realization of how COVID was a signal or marker to start another countdown began to dawn on me. I was now in a rush to get our next book out, but it turned out it was going to have to be three books which we called our Elijah Trilogy.Our 8th book was titled The Restoration of All Things and published in August 2022 as part one of our Elijah Trilogy. Yehshua said that Elijah must come first, and he would restore all things, and then the Messiah would come. So, what are the “all things” that have been lost and who is restoring those things today? Once we know what to look for, then we can see those who are restoring what was lost.Out 9th book, number two in the Elijah Trilogy, is The Abomination That Makes Desolate—The Epilogue. Released January 1, 2023, this book shows you how to know when the abomination was set up. Yes, the countdown to the abomination was already winding down as we raced to publish this book. Most have no clue because they are not looking, having not seen any of the works Yehovah is doing right now worldwide. Yes, we fully expected the abomination to be set up in 2023 and I even went to Israel to specifically look for it. I wrote Prime Minster Netanyahu and the Chief Rabbi and spoke face to face with Rabbi Yehudah Glick on September 10, 2023, but no one believed me. I was so stupid, so naive. Yehshua warned us that when you see the abomination you were to flee. Yehudah did text me on October 7 to say I was right, but it was too late for many people.I found a new shrine to the Blessed Virgin Mary in the very location we expected to discover this abomination. Fortunately for me the abomination was set up on October 6, 2023, exactly 1290 days after the count had begun. To confirm this count date, the second part of Daniel's prophecy also took place 1335 days from that same marker. I experienced over 2000 rockets sent out from Gaza towards Israel and Jerusalem where I was. My understanding of prophetic events was proving to be spot on.My 10th book and 3rd book of the Elijah Trilogy was published in September 2023 and is titled The 10 Days of Awe. This book explains another understanding of the Holy Days from the Feast of Trumpets until the Day of Atonement. These 10 days are likened to the final 10 years before Satan is locked away with the Great Tribulation ending at that time. These 10 years are also connected to the curses of Revelation, as well as the 10 plagues of Egypt. I explain in this book about the curse of the Sotah woman of Numbers 5 and how each of the 10 plagues are what Yehovah is doing to show how the false gods have no power at all. My 11th book, The Stones Cry Out, published September 5, 2024, was originally going to be one book explaining all the various proofs we have discovered, demonstrating when the Sabbatical and Jubilee years are throughout history.You can know; it is not a mystery.As I began to write The Stones Cry Out, I quickly found myself going back, time and time again, to explain how the calendar is behind the confusion of the Sabbatical and Jubilee years. The Rabbis, as they began to write the Mishnah, incorporated wrong understandings, and those errors were written into what became known as the Mishnah, the Jerusalem and Babylonian Talmud and then the Mishneh Torah. The expulsion from the land and subsequent persecutions in trying to send out messengers to report the barley being found, or the crescent moon being seen, proved to be increasingly dangerous over time. All of these things took place over 14 centuries.Then as I was working on The Stones Cry Out, I discovered that many people were now accepting the Zadok calendar as factual. This is when we pivoted to include all the details of the various calendars that have crept back into public knowledge today and are being used to mislead new people who are just starting to learn about the calendar. All of this was directly connected to the period starting with the Hasmonaeans, up to the destruction of the Temple. Then with the compiling of the Mishnah, the studies that led into the writing of the Jerusalem Talmud, then the Babylonian Talmud, and finally the Mishneh Torah, each error that was added was compounded over time.The Stones Cry Out Part 1 explains the history of how each compilation of the Oral Torah incorporated errors, leading the followers thereof away from the actual Torah. In understanding these facts, it is then possible to understand more readily how the Sabbatical and Jubilee years were then mixed and later changed. By explaining all this history, I am able to help you, the reader, understand the tombstones when most authorities do not. They have assumed, to their error, the Hillel calendar to have always been used since Mount Sinai. Not understanding the history of the calendars is why most authorities dismiss the tombstones as too confusing to use. Once you understand The Stones Cry Out Part 1, Part 2 will be very easy to grasp.My 12th book, The Stones Cry Out Part 2, published in December 2024, utilizes the knowledge that there are multiple calendars being used throughout history. Reconciling them all into one cohesive chronology has been the difficulty of all chronologists. It is the lack of understanding about the various calendars why many of the Jubilee experts dismissed so many of the historical artefacts that were available to them.Some proofs are undeniable, while others are weak if they have to stand on their own. It is with a great sense of pride that I share with you what I have been able to document and what we now currently know about the Sabbatical and Jubilee proofs in our possession.Ladies and Gentlemen, this book should have actually been the first book I presented. When I began to understand the Sabbatical and Jubilee years in 2005, at that time I only had 11 Sabbatical years as a reference. From just those 11, I was able to prove a 2nd Jubilee year. Considering we only knew about one Jubilee year prior to this discovery and proof, I was excited. With just these 12 proofs, I have come to understand all the prophecies I have shared with you over the years in all of our books.All of these books, all of this understanding was only possible because of the understanding gained from the knowledge revealed through the Sabbatical and Jubilee cycles by Yehovah. They truly are the foundation or KEY to understanding all end-time prophecy.We have 84 Biblical & historical records recording 63 Sabbatical years and 5 Jubilee years. When all 68 are combined, they prove beyond all doubt when to keep the Sabbatical and Jubilee years. It has been my passion since 2005 to discover and explain these mysteries. As I have proven when the Sabbatical and Jubilee years are to be kept, Yehovah has revealed the profound meanings of many prophecies hidden by not understanding the Jubilee cycles. As I have learned them, I have shared these discoveries in each of my books in order for you, the reader, to also understand their profound meanings and grow closer to Yehovah God. It is for this purpose that I have created our website, Sightedmoon.com, and spent all this time and energy in producing these books—to help you to understand. I pray I have succeeded in helping you to understand. May they all be a blessing to you as well.You TubewebsiteFree Books

Send us a textWe're sitting down with Jared Lorimer, a young adult from Australia who grew up in WCG…AFTER the splits, to talk about:✔️ What it was like growing up in WCG post-split✔️ The awkward silence around sin✔️ And the healing that comes when we finally bring it into the lightThis is a conversation about holding onto the truth + Christ in the midst of false teachings and the courage to deal with what's been left unsaid for too long.

In this episode of WCG Talks Trials, Sandy Smith, senior vice president, clinical solutions & strategic partnering, WCG, is joined by Tiffany Pierce, director, clinical trials core, Henry Ford Health System, to discuss resilience in clinical research.As the landscape of clinical trials faces evolving challenges, they explore how organizations and institutions, like Henry Ford Health, are addressing disruptions, uncertainties, and changes at the federal level. Learn about innovative strategies to enhance trial efficiency, including role clarity, flexible workflows, and diversifying research portfolios.With a focus on maintaining forward momentum in trials and remaining nimble, they discuss actionable solutions to administrative burdens and enhance the efficiency and speed of trial completion. This episode offers invaluable guidance for professionals seeking to stay agile and adapt to ongoing changes in the clinical trials. HOST: Sandy SmithSPEAKER: Tiffany Pearce

WASH-FM's Jenni Chase is our special Host this week and spoke to Cindy Schelhorn: Senior Director, Communications and Marketing, Alzheimer's Association National Capital Area Chapter, and Gina Willoughby: President and CEO, WCG, Inc., Alzheimer's Association National Capital Area Chapter Board Member/Volunteer and organizer of the Workout To End ALZ fundraiser.  June is Alzheimer's And Brain Awareness Month and we discuss risk factors, symptoms, healthy habits and more info logon to alz.org

Dive into the world of generative AI with Silvio Galea, chief data analytics officer, WCG, and Kyle Miller, lead data scientist, WCG. In this compelling episode of WCG Talks Trials, we explore how Generative AI can improve clinical research workflows from meticulous data entry to efficient data validation. Uncover the technology behind AI's ability to assist in document updates, highlight transcription biases, and digitize complex data for predictive analytics. Understand the importance of human oversight and practical applications that can optimize how clinical trials are conducted. Whether you're curious about AI's role in reading dense documents or leveraging pipelines for innovation, this episode provides the insights you need.Guests:Silvio Galea, chief data and analytics officer, WCGKyle Miller, lead data scientist, WCG

In this episode of WCG Talks Trials, join Silvio Galea, chief data and analytics officer, WCG, and Melissa Hutchens, vice president of research and benchmarking, WCG, as they discuss the transformative role of AI in clinical trials. Discover how generative AI and other AI technologies are enhancing the quality of clinical trials, reducing cycle times, and cutting costs. The episode covers the benefits, barriers, and concerns associated with AI, and explores its applications in drug discovery, participant recruitment, trial design, and more. Tune in to learn about the latest advancements in AI and how they are shaping the future of clinical trials.  Guests: Silvio Galea, chief data and analytics officer, WCG Melissa Hutchens, vice president of research and benchmarking, WCG 

Join us for "Breaking Down Site Complexities and Start-Up Barriers in Clinical Trials" as we uncover the complexities of site management and the barriers to effective study start-ups. Discover the top issues impacting research sites and strategies to overcome them, including trial complexity, start-up hurdles, and long initiation timelines.  Learn how effective communication, teamwork, and clear processes can drive success, and the importance of human connections and inclusivity in clinical research. Get practical advice for improving site readiness and trial efficiency from our expert guests.  Don't miss this essential episode on navigating the evolving clinical trial landscape at sites. Guests:Jessica Thurmond, program director, WCG Pat Harrington, senior vice president, Clinical Solutions & Strategic Partnering, WCG Brad Gruener, vice president, Site Services, WCG 

Join us for a compelling episode of WCG Talks Trials where we take a look into the rewarding world of clinical trials and clinical development. In this episode, George Cokenakes, director of clinical services, review solutions, WCG, speaks with Dr. James Januzzi, a renowned cardiologist at Massachusetts General Hospital, and chief scientific officer at Baim Institute for Clinical Research. Dr. Januzzi shares his inspiring journey, highlighting the significance of clinical trial participation and the diverse opportunities that can shape a medical career. Learn from Dr. Januzzi's extensive experience in clinical research, including his work on cardiac biomarkers, drug therapy development, and involvement in various therapeutic areas. Discover how career decisions and active engagement in clinical trials can open doors to numerous possibilities and significantly impact patient care. Tune in for this insightful conversation and gain valuable advice for budding clinicians and researchers.  Speakers: George Cokenakes, PMP, director of clinical services, review solutions, WCG James Januzzi, MD, FACC, cardiologist, Massachusetts General Hospital and chief scientific officer, Baim Institute for Clinical Research 

In this episode of "WCG Talks Trials," host Geoffrey Schick, director of strategic site partnerships, WCG, is joined by fellow MAGI@home 2024 speakers Sandy Smith, Jess Thompson, and Wesley Warren. They share their unique perspectives and key takeaways from this year's virtual conference, including discussions on contract negotiations, the evolving role of advanced practice practitioners, and the collaborative panels featuring both site and sponsor/CRO insights. The episode also recaps the impactful session on the FDA's Diversity Action Plan and what it means for the future of clinical trials. Tune in to hear about the dynamic energy, valuable connections, and innovative challenges that make MAGI and MAGI@home standout events in clinical research. Don't miss out on the exciting plans for MAGI 2025 in Boston, where trends will continue to evolve and new opportunities will emerge. Guests: Geoffrey Schick, MBA, CHRC, Director of Strategic Site Partnerships, WCG  Sandy Smith, RN, MSN, AOCN, Senior Vice President, Clinical Solutions & Strategic Partnerships, WCG Jess Thompson, MS, MBA, PMP, Founder, ACRPM.org Wesley Warren, J.D., Executive Director, Research Strategy & Partnerships, City of Hope 

Lori Abrams has been a consultant for the past year and a half, helping Organizations accomplish representation in their clinical trials. This has been achieved by developing patient and community focused Diversity Strategy Action Plans, incorporating the patient and caregiver's voice into decision-making, and bringing tangible solutions to the visible and invisible barriers that prevent representative recruitment and retention. Her last role was Vice President of patient advocacy and clinical research diversity at WCG. Abrams and her team worked to ensure that each clinical trial enrolled a diverse group of patients from underserved populations by facilitating culturally appropriate dialogue between patients, care providers, community members and trial stakeholders. The feedback and interactions from these groups garnered significant recommendations for the sponsors, but importantly, empowered diverse community members. The Team also worked with several pharmaceutical companies to develop Diverse Strategy Action Plans both for the Sponsor and the sites. As the Director of Advocacy, Diversity & Patient Engagement in Global Development Operations at Bristol-Myers Squibb (BMS) she has built a Team that developed innovative and unique advocacy approaches that brought BMS clinical trial awareness and accessibility to patients, physicians, and caregivers. The Team also developed many relationships with minority-focused health and community-based organizations, to increase diversity in BMS clinical trial populations. The Team also focused on educating the internal BMS workforce on the barriers, concerns and daily life of patients and caregivers. This was achieved through quarterly “Voice of the Patient” seminars, art shows by patients, patient videos and internal teleconferences where colleagues could ask the Team questions. Lori came to Bristol-Myers Squibb in 1998 as a Sr. Clinical Scientist in the Virology Group. During her first six years she was the Clinical Working Group Lead on both Videx EC and Reyataz. She joined the Drug Development Learning & Collaboration Team in 2003 managing a team of learning professionals. Prior to joining BMS, Lori was both a study coordinator in HIV/AIDS related clinical trials and a patient advocate at the National Institutes of Health and the Henry M. Jackson Foundation for Military Medicine. Lori partnered with many patient advocacy organizations to bring the plight of the military's HIV program to the public and integration into the HIV/AIDS overall arena. Additionally, she successfully lobbied Congress to gain support for the military's HIV Program and obtained an increase in funding of 20 million per year. Her work was recognized with a nomination by Congressman Steny Hoyer (House Majority Leader) to be a delegate to the White House Conference of HIV/AIDS, and an award on World AIDS Day by Congresswomen Constance Morella. Lori completed her undergraduate studies at the University of Maryland and received a Graduate Certificate in Organization Development from the NTL Institute for Applied Behavioral Sciences.

In this episode of WCG Talks Trials, host Sandy Smith, senior vice president of clinical solutions and strategic partnering at WCG, dives into the highlights of the Florence Healthcare Research Revolution event. Sandy is joined by industry experts Andrea Bastek, vice president of innovation at Florence, and Lauren Sobocinski, senior vice president of strategic alliances at WCG, to discuss transformative insights from the event. Discover the latest trends shaping clinical research, including site engagement, protocol complexity, and effective sponsor-site relationships. Tune in for a compelling discussion on how collaborative efforts and innovative technologies are driving positive change in the clinical trial landscape. 

In this episode of WCG Talks Trials, host Kelly FitzGerald sits down with Dr. Currien MacDonald, Medical Chair Director at WCG, and Sara Reed, a participant in two psychedelic clinical trials, to explore the evolving landscape of psychedelics research. Dr. MacDonald shares his expertise on the growing acceptance of psychedelics in clinical settings, recent FDA updates, and the inner workings of ongoing trials. Later, Sara provides a firsthand account of her experiences as a trial participant, offering unique insights into how psychedelics are being tested as potential therapeutic options. Tune in to learn more about aligning clinical practice with patient experience in this emerging field.

Send us a textJoin us as we sit down with licensed therapist Debbie Caudle to unpack what we went through as a community through the WCG split, subsequent church splits, and the trauma that followed.

Join Desiree Underwood-Williams, director of project management organization at WCG and guest Steve Smith, CEO of SteveSmithPlans LLC and facilitator of the WCG Patient Forum, as they recap the latest Patient Forum Focus Session on breakthrough science and community engagement. Discussion highlights include:The impact of medical diagnoses on families with Sickle cell disease and melanoma.New research in cell and gene therapy that's directly impacting Sickle cell  disease and melanoma patients.New diversity laws shaping the future of drug development.Community engagement and how patients can get involved in their care.And more insights into the WCG Patient Forum, now in its fifth year.Tune in to learn more about clinical research, community engagement, and the latest developments in patient care.

In this episode of WCG Talks Trials, we are joined by host Joanne Thomas, Clinical Reviewer and Patient Advicate at WCG, along with our guest Currien MacDonald, WCG's Medical Chair Director. This episode covers the roles of IRB in ethical clinical research, frequently asked questions, and a general overview of the IRB's role in clinical trials. 

This episode of WCG Talks Trials addresses site feasibility challenges impacting the clinical trials industry. Join Michelle Yu, associate director of clinical strategy at WCG, and our guest Trevor Cole, director of client delivery, site and strategic operations for WCG, as we discuss approaches to adopt innovative feasibility and site start-up solutions.Here are links to documents referenced in this episode: Recommendations to Streamline and Standardize Clinical Trial Site Feasibility Assessments: An ASCO Research Statement (Main article)Recommendations to Streamline and Standardize Clinical Trial Site Feasibility Assessments: An ASCO Research Statement (PDF Data Supplement)

Mayco member for safety and security, JP Smith weighs in on the agreement by CoCT, WCG and SAPS to bolster safety and security across Cape Town.See omnystudio.com/listener for privacy information.

Western Cape Premier Alan Winde explains the outcomes of the cabinet meeting where the WCG has called for a larger cut from the national budget.See omnystudio.com/listener for privacy information.

Join our Chief Analytics Officer Silvio Galea, along with Dr. Donna Snyder & Dr. Barbara Bierer to discuss opportunities on the ethical and regulatory challenges regarding artificial intelligence in clinical trials. The discussion is focused through the lens of the IRB review, and how a multi-stakeholder task force led by the Multi-Regional Clinical Trials (MRCT) Center of Brigham and Women's Hospital and WCG will address the growing need for guidance in this rapidly evolving area of research.

In this episode of WCG Talks Trials, we are joined by WCG clinical science experts as they discuss traditional measurement challenges for PTSD trials and how the use of an electronic CAPS-5 scale is improving administration and scoring errors. Tune in as we discuss the CAPS-5 scale, the opportunities and benefits of using an electronic version to help standardize scale administration and scoring across clinical research, and the promising results to date. 

The Chicago Bears have selected Iowa punter Tory Taylor in the fourth round. Taylor Doll is joined by WCG's Lead Draft Analyst, Jacob Infante, for some immediate thoughts here.

The Chicago Bears have selected Washington wideout Rome Odunze with the ninth overall pick in the 2024 NFL Draft. In a quick T Formation Conversation, host Lester Wiltfong and WCG's Lead Draft Analyst, Jacob Infante, break it down!

It's finally official! The Chicago Bears have selected USC quarterback Caleb Williams with the first overall pick in the 2024 NFL Draft. In a quick T Formation Conversation, host Lester Wiltfong and WCG's Lead Draft Analyst, Jacob Infante, break it down here.

A new MP3 sermon from Reformed Presbyterian Church of Oswego is now available on SermonAudio with the following details: Title: WCG 23-24 Magistrate & Marriage Subtitle: Westminster Conf. of Faith Speaker: Gabriel Wingfield Broadcaster: Reformed Presbyterian Church of Oswego Event: Bible Study Date: 4/24/2024 Length: 63 min.

A tradition unlike any other! WCG and Bootleg Football's EJ Snyder joins to preview the NFL Draft. We break down the top ten and try to figure out who will be remaining at nine for Chicago. We discuss trade down options in the mid-first and second rounds and look at options at 75 and 122 as well!

We may be saying goodbye to the WCG channel, but it's a new beginning for our whole podcast team covering the Bears at 2nd City Gridiron. Learn more about your ad choices. Visit podcastchoices.com/adchoices

We may be saying goodbye to the WCG channel, but it's a new beginning for our whole podcast team covering the Bears at 2nd City Gridiron. Learn more about your ad choices. Visit podcastchoices.com/adchoices

aprende el vocabulario de compras en tiendas, supermercados, pulgas etc. no olviden aprenderse vocabulario de productos que compran usualmente para complementar su vocabulario. WCG

In this episode, we welcome award-winning photographer and filmmaker, Esteban Toro. Esteban also serves as Adobe's Sr. Community Relationship Manager and is based in New York City. In our chat, he shares his origin story, how he learned photography, on through becoming an ambassador for brands such as Sony and BenQ. He also talks about his role at Adobe supporting the creative community of filmmakers and editors — and sheds light about recent developments in post workflows, A.I., and much more. The Making Of is presented by AJA Video Systems.Versatile color management and conversion with AJA ColorBoxFrom film to live production, color is an art. Achieving the right look requires a combination of talent and access to tools like AJA ColorBox. The color management and conversion box has quickly become a favorite among DITs with camera log, HDR, and WCG support, 12G-SDI and HDMI 2.0 connectivity, and unparalleled color processing. Find out why.ZEISS Conversations with Meena SinghJoin the ZEISS Conversations webinar featuring renowned Director of Photography Meena Singh on Thursday, March 28th at 12pm PST / 3pm EST. Hear her insights about using ZEISS Supreme Prime Radiance lenses to create the look for the notable romantic comedy film, "Wedding Season." They will also discuss how she created the visual language for Sundance 2024 selected short film “Guts” and several documentary projects. Sign up for free hereFrom our Friends at Videoguys…The Canon EOS C70 offers exceptional cinema capabilities in a compact package. Enjoy stunning images with a 4K Super 35mm DGO Sensor and all the built-in features you could ask for, including ND Filters, mini XLRs, direct touch rotatable LCD screen, Dual Pixel CMOS Autofocus, and excellent battery life. Making the EOS C70 even more powerful is compatibility with Canon's expanding line of high-performance RF Lenses.Check it out here!Book of the Month: Woke Up This Morning: The Definitive Oral History of The SopranosExpanding on their hit Talking Sopranos podcast with exclusive interviews for the book with the cast, crew, producers, writers, directors and creators, stars Michael Imperioli and Steve Schirripa deliver the definitive oral history of the landmark television series and streaming hit The Sopranos. Packed with untold stories from behind the scenes and on the set, they're spilling all the secrets.Get a copy herePodcast Rewind:March 2024 - Ep. 27…The Making Of is published by Michael Valinsky.If you'd like to promote your products to over 12,000 leading film, TV and video industry pros reading this newsletter, please email us: mvalinsky@me.com Get full access to The Making Of at themakingof.substack.com/subscribe

All signs are pointing toward Caleb Williams being a Chicago Bear! The Chicago Bears had a large contingent at USC's Pro Day this week and WCG's EJ Snyder was in attendance in Los Angeles! He joins Bill Zimmerman to discuss what he witnessed in LA and what makes Caleb Williams such a unique prospect. Learn more about your ad choices. Visit podcastchoices.com/adchoices

All signs are pointing toward Caleb Williams being a Chicago Bear! The Chicago Bears had a large contingent at USC's Pro Day this week and WCG's EJ Snyder was in attendance in Los Angeles! He joins Bill Zimmerman to discuss what he witnessed in LA and what makes Caleb Williams such a unique prospect. Learn more about your ad choices. Visit podcastchoices.com/adchoices

In the most recent episode of WCG Talks Trials, we are joined by three industry experts, Amy Thue and Shelby Ward from WCG, and Russell Lampman from Merck to discuss the topic of optimizing vendor support, and ultimately the success, of clinical trials.Listen in as we dive into feedback and perspectives from both the sponsor and vendor side of the table—for valuable take-aways and insights into how vendor support is best aligned across all stakeholders.

How should the Chicago Bears approach this all-important offseason? Join Bill Zimmerman and his panel of Pro Football Focus' Brad Spielberger (free agency and salary cap), Bear Report and WCG's Aaron Leming (all-around knowledge) and Bootleg Football and WCG's EJ Snyder (NFL Draft) as they evaluate the Chicago Bears roster, work free agency and sign new players and navigate the NFL Draft! It's a long episode but worth it! Check out a great look at how the Bears' could approach this all-important 2024 offseason! Learn more about your ad choices. Visit podcastchoices.com/adchoices

How should the Chicago Bears approach this all-important offseason? Join Bill Zimmerman and his panel of Pro Football Focus' Brad Spielberger (free agency and salary cap), Bear Report and WCG's Aaron Leming (all-around knowledge) and Bootleg Football and WCG's EJ Snyder (NFL Draft) as they evaluate the Chicago Bears roster, work free agency and sign new players and navigate the NFL Draft! It's a long episode but worth it! Check out a great look at how the Bears' could approach this all-important 2024 offseason! Learn more about your ad choices. Visit podcastchoices.com/adchoices

In this episode, we welcome Emmy-nominated Composer, Score Producer and Musician Chris Ruggiero. Chris has worked on films such as Emily the Criminal, Swallow, The Martha Mitchell Effect, Minding the Gap, Hooligan Sparrow, “Soundbreaking: Stories from the Cutting Edge of Recorded Music,” One Child Nation, Plan C, Camp Courage, episodes of “American Masters" and “American Experience” — and Resynator, which is premiering at SXSW this month. In our chat, we hear Chris' backstory, his path from working at MTV, to creating jingles for brands, on through scoring many of today's top independent films and documentaries. The Making Of is presented by AJA Video Systems.Versatile color management and conversion with AJA ColorBox From film to live production, color is an art. Achieving the right look requires a combination of talent and access to tools like AJA ColorBox. The color management and conversion box has quickly become a favorite among DITs with camera log, HDR, and WCG support, 12G-SDI and HDMI 2.0 connectivity, and unparalleled color processing. Find out why.ZEISS Conversations with Meena SinghJoin the ZEISS Conversations webinar featuring renowned Director of Photography Meena Singh on Thursday, March 28th at 12pm PST / 3pm EST. Hear her insights about using ZEISS Supreme Prime Radiance lenses to create the look for the notable romantic comedy film, "Wedding Season." They will also discuss how she created the visual language for Sundance 2024 selected short film “Guts” and several documentary projects. Sign up for free hereMovie Book of the Month: Space Odyssey: Stanley Kubrick, Arthur C. Clarke, and the Making of a MasterpieceThis is the definitive story of the making of 2001: A Space Odyssey, acclaimed today as one of the greatest films ever made, including the inside account of how director Stanley Kubrick and writer Arthur C. Clarke created this cinematic masterpiece. Author Michael Benson explains how 2001 was made, telling the story primarily through the two people most responsible for the film, Kubrick and science fiction legend Arthur C. Clarke. Benson interviewed Clarke many times, and has also spoken at length with Kubrick's widow, Christiane; with visual effects supervisor Doug Trumbull; with Dan Richter, who played 2001's leading man-ape; and many others.A colorful nonfiction narrative packed with memorable characters and remarkable incidents, Space Odyssey provides a 360-degree view of this extraordinary work, tracking the film from Kubrick and Clarke's first meeting in New York in 1964 through its UK production from 1965-1968, during which some of the most complex sets ever made were merged with visual effects so innovative that they scarcely seem dated today. A concluding chapter examines the film's legacy as it grew into it current justifiably exalted status. Available hereFrom our Friends at Broadfield…The Atomos Ninja bundled with Atomos Connect combines the newest 5" monitor/recorder & playback device with the latest Atomos Cloud features enabled by Atomos Connect. The free 6-month subscription to Atomos Cloud Studio enables camera-to-cloud, remote collaboration and review, cloud editing, live production and streaming. This complete solution will even include an accessory kit with rechargeable batteries, fast-charger, screen protector, travel case and more!Browse hereResource of the Month: The Daily Drop“The Daily Drop” is all about the tech, craft and business of producing content. The ongoing daily series (Mon-Fri) from Jem Schofield of theC47 focuses on video production and filmmaking with a core focus on education.Here's a recent episode that give's Jem's initial thoughts on OpenAI's Sora and how it might impact our industry…More episodes available here Upcoming L.A. Event:Cinelease Open HouseCinelease, known for providing the industry's most extensive array of grip, electrical and lighting equipment and full-service studios, opens its doors for a day of talks, tech, live music, games, food truck favorites, drafts & sodas, and out of this world presentations. The festivities run from noon to 8pm on March 16, 2024 at Cinelease headquarters in Los Angeles.Cinelease has lined up something for everyone at their let-your-hair-down Open House: Cutting-edge tech from AC Lighting, ACT (AC Power), Aputure, ARRI, Camera Car, Creamsource, Elation, Illumination Dynamics, INDU, InnerCircle, Jagoteq, JL Fisher, K5600, Kino Flo, KOTO, LA North Studios, LiteGear, Leitz, Lightscape, LRX, Maccam, Matthews Studio Equipment, NBCUniversal / Cineo, Nanlux, Osram, Power Gems, Roe Visuals, Rosco, RST Visions in Color, Sony, Sumolight, TRP, RT Pro, TMB and more. Learn more hereFeatured NYC Event: Cine Gear NY | March 14-16, 2024Mark your calendars for March and head on out to the thriving Industry City complex along the Brooklyn Upper Bay waterside. Cine Gear's studio-style event is gathering steam as state-of–the-art technology brands are preparing to reveal their latest & greatest gear in the historic Paper Factory Hall. New this year is Photo Focus, a one-day educational event dedicated to the art and craft of Still Photography.Get your Free Passes herePodcast Rewind:Feb. 2024 - Ep. 26…The Making Of is published by Michael Valinsky.If you'd like to promote your company to over 11,500 leading film & TV pros reading this newsletter, please email us at: mvalinsky@me.com Get full access to The Making Of at themakingof.substack.com/subscribe

In this episode of WCG Talks Trials, we are joined by MAGI@home Steering Committee members, Jennifer Peterson, Director, Head of Clinical Quality at M3 Wake Research, and Geoffrey Schick, Director, Strategic Site Partnerships at WCG. Led by Carmin Gade, Chief Marketing Officer at WCG, the discussion will delve into the insights and value MAGI events provide that enable attendees to achieve success in their roles and professional development.

This episode of WCG Talks Trials, hosted by Kelly Fitzgerald, Executive IRB Chair and Vice President of IBC Affairs at WCG, dives into the topic of diversity and inclusion with technology in decentralized clinical trials (DCTs). The episode explores the transformative opportunities that DCTs present for addressing diversity gaps in clinical research. The discussion features a panel of experts, including Otis Johnson, former Chief Diversity, Inclusion, and Sustainability Officer at Clario; Archana Sah, a seasoned clinical development leader with a focus on oncology and healthcare technology; and Ken McCann, a physician with a background in pediatrics and a keen interest in social determinants of health. The panelists share insights on how DCTs can improve accessibility, overcome barriers, and enhance representation in clinical trials, emphasizing the potential for these trials to be a game-changer in making clinical research more equitable and inclusive. Guests:Archana Sah MS (Pharm.) PMP Otis Johnson, PhD, MPAKen McCann, MD 

Listen to the latest episode of WCG Talks Trials to hear from experts on the importance of patient advocacy in clinical research and key takeaways from WCG's 2023 Patient Forum. We'll summarize how the patient forum elevates the voices of those changing drug development for the better and recap breakthroughs and best practices shared during the most recent event.Discover more about patient and researcher collaboration, expanding diversity, equity, and inclusion in trials, and the latest advocacy-driven technology, science, and policy breakthroughs leading to modernized clinical research.  Guests:Desiree Underwood-Williams, PMP, CLSSBB, Director, Project Management Office, WCGSteve Smith, President, Patient Advocacy, WCG 

Listen to the latest episode of WCG Talks Trials to hear from experts on the importance of diversity, equity, and inclusion in clinical research and how intersectionality plays a role in promoting DE&I. We'll discuss why diversity is pivotal for comprehending the full spectrum of clinical care mechanisms and review effective DE&I strategies being deployed today. Discover how communities can be more actively engaged in clinical research and hear real-world examples of success stories in promoting diversity, equity, and inclusion within clinical research.Moderator:Scott J. Hunter, PhD - Senior Scientific Expert, Neurodevelopmental and Rare Pediatric Diseases, WCGSpeakers:Sonya Dinizulu, PhD - Associate Professor of Psychiatry and Behavioral Neuroscience, University of Chicago Desiree Underwood-Williams, PMP, CLSSBB – Director, Project Management Office, WCG 

In episode three of WCG Talks Trials, two WCG experts discuss key findings from the 2023 Avoca State of the Industry Report, which provides a 360-degree view on motivators and deterrents to clinical trial participation.Listen in as we dive into feedback from perspectives across all clinical research stakeholders — sponsors, providers, sites, and patients — for valuable take-aways and insights into the trial experience.Speakers:Crissy MacDonald, PhD, Vice President, Client Delivery, WCG AvocaGina DiCindio, Associate Director, Industry and Client Research, WCG Avoca

Let's break down the Chicago Bears' initial 53-man roster on a brand new T Formation Conversation with host Lester Wiltfong and his special guest, WCG's Lead Draft Analyst, Jacob Infante. Learn more about your ad choices. Visit podcastchoices.com/adchoices

In episode two of WCG Talks Trials, we are joined by two WCG experts to discuss overcoming common enrollment challenges and how DE&I, technology, and protocol design factor into enrollment success.Listen in as we delve into the critical topic of common enrollment barriers in clinical trials, how to improve enrollment by focusing on DE&I efforts, the importance of site-centric and patient-centric technologies, and how thoughtful protocol design plays a significant role in enrollment success.Speakers:Dawn Sauro, Chief Growth Officer, WCGJamie Harper, MHA, CCRP - Vice President, Site Solutions & Engagement at WCGTyler Bye - Director, Site Solutions & Product Strategy at WCG

WCG podcast host Jeff Berckes brought in a microphone to Chicago Bears training camp to record interaction with fans. Before security cut him off from recording more, he talked to Dave Scarbrough about the difference between QB trainers and QB coaches, and then record predictions and favorite players from the back row of the bleachers from Tuesday's practice. Learn more about your ad choices. Visit podcastchoices.com/adchoices

WCG's Lead Draft Analyst, Jacob Infante, took questions from Chicago Bears fans on a recent LIVE Twitter Spaces and we share the uncut show right here. Learn more about your ad choices. Visit podcastchoices.com/adchoices

WCG's Lead Draft Analyst, Jacob Infante, recoded a live Twitter Spaces Q&A about Chicago Bears training camp, draft prospects, and so much more. Listen to his uncut Spaces right here. Learn more about your ad choices. Visit podcastchoices.com/adchoices

WCG's Lead Draft Analyst, Jacob Infante, did a live Q&A that can be heard here where he gave his thoughts on the Chicago Bears' upcoming training camp, their wide receiver room, Justin Fields, and so much mere... Learn more about your ad choices. Visit podcastchoices.com/adchoices

In the first episode of our new podcast series, WCG Talks Trials, we are joined by three industry experts, Lisa Ballance from Virginia Commonwealth University, John Musser from Florida Cancer Specialists and Research Institute, and Dan Otap from Genentech, to discuss the topic of overcoming site challenges and addressing site burden.Listen in as we discuss the results of WCG's recently published 2023 Clinical Research Site Challenges Survey Report, gain insights from our guests on solutions their organizations have implemented to reduce site burden, and share perspectives on how sites, sponsors, and CROs can work to improve site and trial efficiency. Speakers: Sandy Smith, RN, MSN, AOCN  Senior Vice President, Clinical Solutions and Strategic Partnerships at WCG ClinicalLisa Richman Balance Associate Vice President for Research Strategy and Regulatory Affairs at Virginia Commonwealth University John Musser Senior Director, Clinical Research Administration at Florida Cancer Specialists & Research InstituteDan Otap Principal, Alliance and Partnerships Lead at Genentech

Check out our immediate reaction to the Chicago Bears draft pick on a new Bears Banter from Bill Zimmerman as he and WCG's Lead Draft Analyst Jacob Infante let us know all about South Carolina DT Zacch Pickens. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Jeff Berckes is joined by WCG's Lead Draft Analyst, Jacob Infante, to fill us in on Chicago Bears draft pick Travis Bell. The DT from Kennesaw State gives the Bears another body along the interior defensive line as Ryan Poles remakes this defensive front. Learn more about your ad choices. Visit podcastchoices.com/adchoices